However, CD40, glypican 3 (GPC3), Iroquois homeobox 2 (IRX2), FOXO1, EPAS1, and cyclin-dependent kinase inhibitor 1C (CDKN1C) were consistently down-regulated in tumor tissues and GbPDTOs compared to those in normal tissues. This evidence concerns the gene GPC3 and neoplasm.